Opsens To Present at the LD Micro Invitational

FacebookFacebookTwitterTwitterEmailEmailLinkedInLinkedInWhatsAppWhatsAppMessengerMessengerFlipboardFlipboardGmailGmailTelegramTelegramShareShare

QUEBEC CITY, QC / ACCESSWIRE / May 22, 2019 / Opsens Inc. (“Opsens” or the “Company”) (TSX: OPS) (OTCQX: OPSSF), a company focusing mainly on physiological measurements such as Fractional Flow Reserve (“FFR”) and Diastolic Pressure Ratio (“dPR”) in interventional cardiology, will present at the LD Micro 9th Invitational investor conference on Tuesday, June 4, 2019 at 8:40 am PST. Louis Laflamme, Opsens’ President and Chief Executive Officer, will give the presentation and host meetings with investors on both days the event will be held.

The event will take place at the Luxe Sunset Hotel in Bel Air, California on June 4th and 5th.

LD Micro is an independent resource in the microcap space. To register and attend the event, please visit https://www.ldmicro.com/events.

Investors wishing to schedule a meeting with Louis Laflamme should contact Marie-Claude Poitras at marie-claude.poitras@opsens.com.

View Opsens’ profile on LD Micro: https://www.ldmicro.com/profile/OPS.TO.

News Compliments of ACCESSWIRE

About Opsens Inc. (www.opsens.com or www.opsensmedical.com)

Opsens focuses mainly on physiological measurements such as FFR and dPR in interventional cardiology. Opsens offers an advanced optical-based pressure guidewire that aims at improving the clinical outcome of patients with coronary artery disease. Its flagship product, the OptoWire, is a second-generation fiber optic pressure guidewire designed to provide the lowest drift in the industry and excellent lesions access. The OptoWire has been used in the diagnosis and treatment of over 60,000 patients in more than 30 countries. It is approved for sale in the United States, European Union, Japan, and Canada.

Opsens is also involved in industrial activities in developing, manufacturing and installing innovative fibre optic sensing solutions for critical applications.

Contact:

Louis Laflamme, CPA, CA, Chief Executive Officer, 418.781.0333
Robin Villeneuve, CPA, CA Chief Financial Officer, 418.781.0333

SOURCE: Opsens Inc.

View source version on accesswire.com:
https://www.accesswire.com/546180/Opsens-To-Present-at-the-LD-Micro-Invitational

user

Recent Posts

FinThrive Introduces Agentic AI at HFMA 2025 to Help Customers Transform Healthcare Revenue Cycle Management Performance

Company to also highlight advancements in denials and underpayments management and speak to the measurable…

11 hours ago

FinThrive Debuts Denials and Underpayments Analyzer, a Unified Solution for Denials and Underpayments, at HFMA 2025

Next generation analyzer helps hospitals protect revenue before it's lost by delivering timely end-to-end visibility…

11 hours ago

Novo Nordisk A/S: CagriSema 2.4 mg / 2.4 mg demonstrated 22.7% mean weight reduction in adults with overweight or obesity in REDEFINE 1, published in New England Journal of Medicine

Data presented simultaneously at the American Diabetes Association’s® 85th Scientific Sessions, showed mean weight reduction…

14 hours ago

Dr. Anosh Ahmed Advances Chicago Crypto Hub Project as Federal Support for Blockchain Grows

Dr. Anosh Ahmed repurposes West Side warehouse into blockchain innovation center, targeting 250+ jobs and…

14 hours ago

Dr. Anosh Ahmed Advances Chicago Crypto Hub Project Amid National Pro-Crypto Policy Shift

Dr. Anosh Ahmed converts vacant West Side warehouse into blockchain innovation hub, creating 250+ jobs…

14 hours ago

BioAge Labs to Present Preclinical Data on APJ Agonism for Diabetic Obesity and Heart Failure at the American Diabetes Association (ADA) 85th Scientific Sessions

Treatment with apelin receptor agonist enhanced glycemic control and demonstrated cardioprotective effects, with additive benefits…

14 hours ago